RET-IN-30

• Description :

  RET-IN-30 (Compound 28) is a RET inhibitor that exhibits inhibitory activity against both wild-type RET and some of its mutants. RET-IN-30 can inhibit the proliferation of A549 cells and has anti-tumor activity[1].

• UNSPSC :

  12352005

• Target :

  RET

• Related Pathways :

  Protein Tyrosine Kinase/RTK

• Field of Research :

  Cancer

• Smiles :

  FC1=CC(OC2CN(C2)C3=NC=C(C=C3)C4=C5N=CC=NC5=CC(N(CC)CC)=C4)=CC=C1

• Molecular Formula :

  C26H26FN5O

• Molecular Weight :

  443.52

• References & Citations :

  [1]LEE, et al. Novel quinoxaline compounds, manufacturing method thereof, and uses thereof. WO2025084787A1. 2025-04-24.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [3081389-07-0]